Healthcare companies set for deals spree as drug patents expire

The expiration of drug patents often leads to increased competition and can significantly alter market dynamics. As healthcare companies look to consolidate and expand their portfolios, this could lead to a wave of strategic partnerships and acquisitions. The optimism among executives suggests a shift in the industry's landscape, potentially benefiting consumers through increased access to medications and therapies.